Gingicaine Gel, Pina Colada Gel
Product Images NDC 10129-033

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel, Pina Colada (NDC 10129-033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Keep Out Of Reach Of Children (Children Page 001)

This text panel warns that all Gingicaine Gel products should be kept out of reach of children and advises to call a doctor immediately if Gingicaine is ingested or swallowed by a child, following directions accordingly.*

FDA Label Image

Contraindications

This image shows a drug facts or warning text panel detailing contraindications. It advises against using the product in patients with hypersensitivity to ester-type local anesthetics and warns not to use it for teething or in children under 2 years.*

FDA Label Image

Gingi Caine Pina Colada Jar Label

Drug Facts panel for GingiCaine Gel, Pina Colada Flavor, a topical anesthetic gel containing 20% benzocaine as the active ingredient. It includes uses, allergy alert, warnings, directions for use, dosage and administration, and precautions. The label warns against use in children under 2 years, avoiding excessive heat, and provides manufacturer contact information for Gingi-Pak in Camarillo, CA.*

FDA Label Image

Active Ingredients (Gingicaine Active Ingredients 001)

A drug facts panel showing the active ingredient Benzocaine at 20% w/v concentration, with its purpose listed as Oral Anesthetic.*

FDA Label Image

Allergy Alert (Gingicaine Allergy Alert 001)

This drug facts panel contains an Allergy Alert cautioning against the use of the product by individuals with a history of allergy to any "caine" local anesthetics or FD&C Red #40.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

A text panel titled 'Avoid Excessive heat' indicating temperature guidelines, specifically mentioning to avoid exposure above 40 °C (104 °F). The text is in black and bold for emphasis.*

FDA Label Image

Consult A Doctor Promptly (Gingicaine Consult A Doctor)

A text panel providing warnings and directions for GingiCaine Gel, Pina Colada Flavor. It advises consulting a doctor promptly if severe sore throat symptoms persist, if mouth sores do not resolve within 10 days, or if irritation worsens. It instructs to avoid contact with eyes, keep out of reach of children, seek medical help if excessive amount is swallowed, and not to exceed recommended dosage.*

FDA Label Image

Dosage And Adminstration001 (Gingicaine Dosage And Admin 001)

A partial dosage and administration instruction panel for GingiCaine Gel, Pina Colada flavor. The visible text advises drying the mucosa prior to application and removing excess saliva before use.*

FDA Label Image

Dosage And Adminstration002 (Gingicaine Dosage And Admin 002)

This image shows directions for use of a topical dental gel anesthetic. It advises applying the gel to the affected area for at least one minute and outlines dosage limits, including using up to four times daily or as directed by a dentist or doctor. It also highlights precautions to avoid cross-contamination, use of sterile cotton or gauze, and age recommendations for use in adults and children 2 years and older.*

FDA Label Image

Indications (Gingicaine Indications 001)

Text panel showing indications for GingiCaine Gel, including anesthesia of mucous membranes of the oropharynx, pain minimization for ulcers, needle punctures, deep scaling procedures, matrix band application, and aid during impressions or intraoral radiographs for patients with excessive gag reflex.*

FDA Label Image

Precautions (Gingicaine Precaution 001)

A precautionary text panel advising dentists to avoid applying the product to severely traumatized mucosal areas or the posterior pharynx. It cautions the use of local anesthetics with patients sensitive to ester-type anesthetics and recommends avoiding contact with local anesthetics to prevent sensitization.*

FDA Label Image

Uses (Gingicaine Uses 001)

A text panel labeled 'Uses' listing the conditions for which the product is intended: minor dental procedures, minor gum injury, canker sores, sore throat, and minor mouth or gum irritations caused by dentures or orthodontic appliances.*

FDA Label Image

Inactive Ingredients (Inactive Ingredient Page 001)

A text panel listing inactive ingredients which include Polyethylene Glycol 3350, Polyethylene Glycol 400, and Potassium Sodium Saccharate. No other text or branding is visible in the image.*

FDA Label Image

Purpose (Purpose Page 001)

Text panel describing GingiCaine Gel as a topical anesthetic used by dentists just prior to an injection, typically applied to a patient's gum.*

FDA Label Image

Warnings

Warning text panel for GingiCaine Gel, Pina Colada flavor, specifying that it is for external use only. The warning notes the risk of methemoglobinemia, a serious condition affecting oxygen transport in the blood, and lists symptoms that require immediate medical attention. It also advises not to use this product in children under 2 years of age.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.